WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsOraSure Technologies Inc (OSUR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 24619% more annual revenue ($28.43B vs $115.02M). MDLN leads profitability with a 4.1% profit margin vs -59.8%. MDLN earns a higher WallStSmart Score of 52/100 (C-).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

OSUR

Hold

42

out of 100

Grade: D

Growth: 4.0Profit: 2.0Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.67

$24.25 discount

UndervaluedFair: $66.92Overvalued

Intrinsic value data unavailable for OSUR.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

OSUR2 strengths · Avg: 9.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
29.6%8/10

Earnings expanding 29.6% YoY

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

OSUR4 concerns · Avg: 2.3/10
Market CapQuality
$212.91M3/10

Smaller company, higher risk/reward

PEG RatioValuation
6.192/10

Expensive relative to growth rate

Return on EquityProfitability
-18.3%2/10

ROE of -18.3% — below average capital efficiency

Revenue GrowthGrowth
-28.5%2/10

Revenue declined 28.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : OSUR

The strongest argument for OSUR centers on Price/Book, EPS Growth.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : OSUR

The primary concerns for OSUR are Market Cap, PEG Ratio, Return on Equity.

Key Dynamics to Monitor

MDLN profiles as a value stock while OSUR is a turnaround play — different risk/reward profiles.

MDLN is growing revenue faster at 14.8% — sustainability is the question.

OSUR generates stronger free cash flow (-10M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLN scores higher overall (52/100 vs 42/100) and 14.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

OraSure Technologies Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and internationally. The company is headquartered in Bethlehem, Pennsylvania.

Want to dig deeper into these stocks?